Market Overview

Earnings Calendar Scheduled for July 9th, 2013

Related HITK
Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic Solution, 0.09%
US Stock Futures Up; Jobless Claims Data In Focus
Related WWW
UPDATE: Wolverine Posts Better-Than-Expected Q3 Earnings, Revenue Misses View
Earnings Scheduled For October 14, 2014

Pre-Market:

Hi-Tech Pharmacal (NASDAQ: HITK) - Q4 2013 EPS estimate of $0.68 and revenue estimate of $66.70 million

Wolverine World Wide (NYSE: WWW) - Q2 2013 EPS estimate of $0.34 and revenue estimate of $591.03 million

SemiLEDS (NASDAQ: LEDS) - Q3 2013 EPS estimate of $(0.24) and revenue estimate of $5.17 million

Penford (NASDAQ: PENX) - Q3 2013 EPS estimate of $0.15

After-Hours:

ADTRAN (NASDAQ: ADTN) - Q2 2013 EPS estimate of $0.16 and revenue estimate of $154.16 million

Healthcare Services Group (NASDAQ: HCSG) - Q2 2013 EPS estimate of $0.20 and revenue estimate of $281.77 million

Franklin Covey (NYSE: FC) - Q3 2013 EPS estimate of $0.11 and revenue estimate of $43.28 million

Helen of Troy Limited (NASDAQ: HELE) - Q1 2014 EPS estimate of $0.69 and revenue estimate of $301.50 million

Posted-In: Earnings News Guidance Markets

 

Related Articles (ADTN + FC)

Around the Web, We're Loving...

Get Benzinga's Newsletters